Technical Program | AIChE

Technical Program

Technical Program for the 5th ICME

Please see below for the Technical Program. To view speaker abstracts, please click here.


Start Time End Time  
December 9, 2022 All Eastern US Time
8:00 AM 4:00 PM Registration & Check In
8:30 AM 9:00 AM Breakfast + Morning Coffee
    Day 1
9:00 AM 10:00 AM Opening Statements & Keynote
9:00 AM 9:10 AM Day 1 Introduction by Chairs: Megan McClean, University of Wisconsin-Madison & Mark Charbonneau, Solarea Bio
9:10 AM 10:00 AM KEYNOTE: Domesticating and Engineering Microbiomes across Diverse Environments, Harris Wang, Columbia University
10:00 AM 10:30 AM Morning Coffee Break
10:30 AM 12:25 PM Tools, Standards and Modeling (Development and Use of Microbiomes)

Chair: Megan McClean
10:30 AM 10:35 AM Session Introduction: Megan McClean, University of Wisconsin-Madison
10:35 AM 11:00 AM Genetically stable CRISPR-based tools for engineering microbiota, Tae Seok Moon, Washington University in St. Louis
11:00 AM 11:25 AM Using gnotobiotic mouse models to understand factors influencing microbiome modulation, Amanda Ramer-Tait, University of Nebraska
11:25 AM 11:50 AM Synthetic communities and gnotobiotic mouse models to understand functions of the intestinal microbiome, Barbel Stecher, Ludwig-Maximilians University Munich
11:50 AM 12:10 PM Radical Genetic Code Engineering to Block Viral Infections and Horizontal Gene Transfer, Akos Nyerges, Harvard Medical School
12:10 PM 12:15 PM Lightning Talk: A Chemical Reaction Similarity Based Prediction Algorithm to Identify the Multiple Taxa Required to Catalyze an Entire Metabolic Pathway of Dietary Flavonoids, Ebru Ece Gulsan, Tufts University
12:15 PM 12:20 PM Lightning Talk: Studying Personalized Interventions with Metagenome-Scale Metabolic Models of the Human Gut Microbiota, Christian Diener, Institute for Systems Biology
12:20 PM 12:25 PM Lightning Talk: Targeting Oncogenic Pathogens in Colon Cancer, Kimberley Owen, University College London
12:25 PM 1:25 PM Lunch Workshop by Cerillo: A Novel Co-Culture Method: a Case Study for Improved Bacterial Interaction Studies, Jessica Lee, Cerillo 
1:25 PM 3:00 PM Therapeutics (Clinical Applications and Drug Development) Part 1

Chair: Lauren Popov
1:25 PM 1:30 PM Session Introduction: Lauren Popov, Novome Biotechnologies
1:30 PM 1:55 PM Development of SBD111 as a Medical Food for the Dietary Management of Post-Menopausal Osteoporosis, Mark Charbonneau, Solarea Bio
1:55 PM 2:15 PM Gut Commensals Associated with Inflammatory Bowel Disease Degrade Components of the Extracellular Matrix, Ana Porras, University of Florida 
2:15 PM 2:40 PM VE303, a defined consortia for prevention of Clostridium difficile infection, Greg Medlock, Vedanta
2:40 PM 3:00 PM Engineering Probiotic Strains to Secrete Therapeutic Molecules to Treat Inflammatory Bowel Disease, Kelly Storek, Genentech Inc.
3:00 PM 3:30 PM Afternoon Coffee Break 
3:30 PM 4:15 PM Panel Discussion: Opportunities and Challenges for Microbiome Therapeutics

 Moderator:
Mark Charbonneau

Panel: Greg Medlock, Lauren Popov, Kelly Storek
4:15 PM 5:15 PM Poster Session A
     
December 10, 2022  
9:00 AM 4:00 PM Registration & Check In
9:30 AM 10:00 AM Breakfast + Morning Coffee
    Day 2
10:00 AM 10:30 AM Introduction & Keynote
10:00 AM 10:05 AM Day 2 Introduction by Chair: Megan McClean, University of Wisconsin-Madison 
10:05 AM 10:30 AM KEYNOTE: Greg Medlock, Vedanta
10:30 AM 11:00 AM Morning Coffee Break
11:00 AM 2:30 PM Engineering Microbes and Microbial Communities

Chairs: Megan McClean
11:00 AM 11:05 AM Session Introduction: Megan McClean, University of Wisconsin-Madison
11:05 AM 11:30 AM Towards precision evolution of single microbes and communities, Kiran Patil, University of Cambridge
11:30 AM 11:55 AM Predicting and controlling gene transfer in microbial communities, Lingchong You, Duke
11:55 AM 12:20 PM Genetic Manipulation of Nonmodel Gut Microbes Enables Single-Gene Interrogation in a Complex Microbiome, Chunjun Guo, Weill Cornell Medicine
12:20 PM 1:20 PM Lunch 
1:20 PM 1:45 PM Engineering defined bacterial consortia for therapeutics based on trophic interactions, Gabriel Leventhal, PharmaBiome
1:45 PM 2:10 PM Eco-evolutionary dynamics and metabolic mechanisms in microbial systems, William Harcombe, University of Minnesota
2:10 PM 2:30 PM Targeted DNA Editing Within Microbial Communities, Benjamin E. Rubin, University of California, Berkeley & Brady Cress, University of California
2:30 PM 4:50 PM Engineering Microbes for Sustainable Planet And Industrial Applications Session Chair: Shannon Sirk
2:30 PM 2:35 PM Session Introduction: Shannon Sirk, University of Illinois Urbana-Champaign
2:35 PM 3:00 PM Designing Microbes for Sustainability, Pam Silver, Harvard
3:00 PM 3:25 PM Mechanistic understanding of microbial interactions for the rational design of food cultures, Ahmad Adel Zeidan, Chr. Hansen
3:25 PM 3:55 PM Afternoon Coffee Break 
3:55 PM 4:15 PM Engineering Anaerobic Fungal-Bacteria Consortia for Medium Chain Fatty Acid Production from Lignocellulosic Biomass, Byung-Chul Kim, University of Toronto
4:15 PM 4:35 PM A Rapid Evolutionary Journey Towards Obligate Mutualism, Giovanni Scarinci, Max Planck Institute for Terrestrial Microbiology
4:35 PM 4:40 PM Lightning Talk: Escherichia coli Promoters with Consistent Expression throughout the Murine Gut, Jeremy Armetta, Technical University of Denmark
4:40 PM 4:45 PM Lightning Talk: Engineering a Targeted Probiotic Yeast Drug Delivery System for Treatment of Inflammatory Bowel Diseases, Mairead Heavey, UNC Chapel Hill
4:45 PM 4:50 PM Lightning Talk: Indole-3-Acetate, a Microbiome Derived Tryptophan Metabolite, Provides Protection Against NAFLD and Exhibits Anti-Inflammatory Activity through Adipose-Liver Axis, Karin Yanagi, Tufts University
4:50 PM 5:50 PM Poster Session B
     
December 11, 2022  
8:00 AM 4:00 PM Registration & Check In
8:30 AM 9:00 AM Breakfast + Morning Coffee
    Day 3
9:00 AM 10:00 AM Introduction & Keynote
9:00 AM 9:10 AM Day 3 Introduction by Chair: Mark Charbonneau, Solarea Bio
9:10 AM 10:00 AM KEYNOTE: Resource competition predicts assembly of in vitro gut bacterial communities, KC Huang, Stanford University
10:00 AM 10:30 AM Morning Coffee Break
10:30 AM 12:10 PM Therapeutics (Clinical Applications and Drug Development) Part 2

Chair: Mark Charbonneau
10:30 AM 10:35 AM Session Introduction: Mark Charbonneau, Solarea Bio
10:35 AM 11:00 AM Genetically Engineered Microbial Medicines, Lauren Popov, Novome Biotechnologies
11:00 AM 11:25 AM Jan Peter van Pijkeren, University of Wisconsin Madison
11:25 AM 11:50 AM Leveraging Bacterial Secretion Systems to Develop Therapeutic Designer Probiotics, Cammie Lesser, Harvard Medical School
11:50 AM 12:10 PM Niche Exclusion of a Lung Pathogen in Mice with Designed Probiotic Communities, Kelsey Hern, University of California Berkeley
12:10 PM 1:10 PM Lunch
1:10 PM 2:25 PM Learning Engineering Principles from Natural Communities

Chair: Greg Medlock
1:10 PM 1:15 PM Session Introduction: Greg Medlock, Vedanta Biosciences 
1:15 PM 1:40 PM Bacterial bile acid metabolites affect host physiology, Sloan Devlin, Harvard University
1:40 PM 2:05 PM Engineered Native E. coli Allow Persistent Physiological Change in Conventionally-Raised Hosts, Amir Zarrinpar, UC San Diego
2:05 PM 2:25 PM Metabolic Flux Analysis Identifies Unexpected Metabolite Exchanges in E. coli Co-Culture, Yu Jun Hong, University of Michigan
2:25 PM 2:35 PM Closing Statements, Megan McClean & Mark Charbonneau